Latest news with #GoodRX
Yahoo
3 days ago
- Business
- Yahoo
Jim Cramer Holds Back on GoodRx (GDRX)
We recently published a list of . In this article, we are going to take a look at where GoodRx Holdings, Inc. (NASDAQ:GDRX) stands against other stocks that Jim Cramer discusses. Noting that Cramer has not said anything about GoodRx Holdings, Inc. (NASDAQ:GDRX) in a long time, a caller asked about the company. In response, Cramer said: 'Sometimes, like my Nana Mary said, if you don't have anything good to say about someone, don't say it at all.' A pharmacist assisting elderly customers with their GoodRX codes at a local pharmacy. GoodRx (NASDAQ:GDRX) provides tools that help people find lower prices on prescription drugs, along with subscriptions, telehealth services, and healthcare solutions for both humans and pets. In 2022, when a caller asked about the company during a lightning round, Cramer said, 'These are all no-go. They're in a no-fly zone. You've just got to look at it like that.' For context, GDRX stock has gone down more than 82% since the comment was aired. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
5 days ago
- Business
- Yahoo
Jim Cramer Holds Back on GoodRx (GDRX)
We recently published a list of . In this article, we are going to take a look at where GoodRx Holdings, Inc. (NASDAQ:GDRX) stands against other stocks that Jim Cramer discusses. Noting that Cramer has not said anything about GoodRx Holdings, Inc. (NASDAQ:GDRX) in a long time, a caller asked about the company. In response, Cramer said: 'Sometimes, like my Nana Mary said, if you don't have anything good to say about someone, don't say it at all.' A pharmacist assisting elderly customers with their GoodRX codes at a local pharmacy. GoodRx (NASDAQ:GDRX) provides tools that help people find lower prices on prescription drugs, along with subscriptions, telehealth services, and healthcare solutions for both humans and pets. In 2022, when a caller asked about the company during a lightning round, Cramer said, 'These are all no-go. They're in a no-fly zone. You've just got to look at it like that.' For context, GDRX stock has gone down more than 82% since the comment was aired. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
23-04-2025
- Business
- Yahoo
Why GoodRx Holdings (GDRX) Is Among the Best Telehealth Stocks to Buy Now
We recently published a list of . In this article, we are going to take a look at where GoodRx Holdings, Inc. (NASDAQ:GDRX) stands against other best telehealth stocks to buy right now. According to Grand View Research, the telehealth market size in the US was valued at $42.54 billion in 2024. It is expected to grow at a notable compound annual growth rate of 23.8% between 2025 and 2030. Some of the primary factors supporting this growth include the rising demand for remote healthcare services, large-scale penetration of connected home services, and high internet usage. In addition, the global adoption of smartphones, advancements in technology, and a surge in government initiatives to develop telehealth programs are also supporting market growth. Since the cost of in-person healthcare provision is increasing in the country, telehealth presents a significant opportunity in the healthcare sector. According to McKinsey, around $250 billion of the present US healthcare spending can be virtualized. This includes training for medical professionals, regular check-in appointments for chronic diseases, psychiatric care, and more, all administered and accessed through each individual's preferred device. READ ALSO: and . Some experts view medical, healthcare, and big pharma stocks as immune from trade carnage, making them a safe haven amid the uncertainty brought about by Trump's tariffs. Since Trump's tariffs and macroeconomic uncertainties are causing significant market volatility, we discussed the potential of healthcare stocks as a safe haven amidst the ongoing turmoil in a recently published article on the . Here is an excerpt from the article: On April 8, Mizuho Securities America healthcare sector strategist Jared Holz opined that managed care, particularly the government-centric names, are somewhat safe as they are insulated from tariffs as US-based companies. In fact, the economic slowdown is actually beneficial for them as they want less utilization and less patience through the system, which is how they typically beat numbers. He said that managed care is having a good day, and investors might think about owning some companies in the sector. We sifted through stock screeners, financial media reports, and ETFs to compile a list of 25 telehealth stocks and chose the top 10 most popular among hedge funds as of Q4 2024. The list is ordered in ascending order of hedge fund sentiment. We sourced the hedge fund sentiment data from Insider Monkey's database. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (). A pharmacist assisting elderly customers with their GoodRX codes at a local pharmacy. Number of Hedge Fund Holders: 27 GoodRx Holdings, Inc. (NASDAQ:GDRX) offers a consumer-focused digital healthcare platform that provides free consumer access to convenient medical provider consultations through telehealth, reduced prices for brand and generic medications, and extensive healthcare research and information. It takes the ninth spot on our list of the best telehealth stocks to buy now. On March 3, CNN reported that Mizuho Securities analyst Steven Valiquette noted that the company's market share in the prescription discount segment underwent growth, and its new CEO identified a stronger than expected value proposition for retail pharmacies. This is expected to support GoodRx Holdings, Inc. (NASDAQ:GDRX) in forging future contracting opportunities with retailers. According to the analyst, the company's Manufacturer Solutions segment is also expected to be a key growth driver. Growth in contracted brands is anticipated to drive a 20% growth in 2025. However, despite these positive indicators, GoodRx Holdings, Inc.'s (NASDAQ:GDRX) earnings per share expectations for 2025 and 2026 remain the same, aligning with market expectations. EBITDA and revenue guidance for 2025 also coincides with Wall Street estimates, reflecting stable growth. Overall, GDRX ranks 9th on our list of the best telehealth stocks to buy right now. While we acknowledge the potential for GDRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than GDRX but trades at less than 5 times its earnings, check out our report about this cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
27-03-2025
- Health
- Yahoo
Why medical deserts are on the rise—and how patients there are accessing in-person care
Twenty-one percent of adults without access to a vehicle or public transit went without needed medical care in 2022. It's a sobering stat that points at a real problem: Unlike online shopping or dinner delivery, people need to get to health care to actually receive it. This is trickier in regions where essential medical services are hard to reach, often called "medical deserts." In these areas, even routine medical visits can become ordeals. Take the simple act of picking up a prescription. For many of us, that requires only a quick drive (or even walk): A majority of Americans live within two miles of a pharmacy. But the U.S. has seen a 15% decline in retail pharmacies since 2021, leaving many communities without easy, convenient access to medications, Lyft explains. Data from GoodRX suggests that in 40% of counties, residents have to travel over 15 minutes to get to nearby pharmacies—but it's in the rural states of North Dakota, Alaska, and Montana, and the more urban states of Texas and Georgia—where riders have to travel the farthest. The situation is particularly striking in Apache County, Arizona; Woodford County, Illinois; and Delaware County, New York—which are the three largest counties where 100% of residents live in pharmacy deserts. Long pharmacy rides were generally more common in rural counties, with under 50 people per square mile. Among high-density counties, pharmacy deserts are 30% more likely to occur in counties with a higher share of African American residents. Pharmacies are only part of the problem—there are also disparities in access to medical care. The average American lives roughly 5 miles away from a hospital, and many have to travel over 10 miles for routine health care visits. This distance is not just an inconvenience: Living far from a medical facility is associated with fewer visits to a primary care physician and worse outcomes for patients with cancer and chronic conditions. GoodRX data suggests that across the U.S., 20% of counties are hospital deserts, where the closest hospital is generally over 30 minutes away. These rates are twice as high in Alaska, North Dakota, and Missouri, and there are several counties where all residents have to travel over 30 miles to get to a hospital–those with populations over 38,000 include Valencia County, New Mexico; Webster County, Missouri; and Kendall County, Texas. While health deserts have long been a problem in the U.S., rideshare is helping to cross them. Visits to and from health care facilities have emerged as a major use case for rideshare services, with 26% of riders in a recent Lyft survey reporting using rideshares to access health care services. To meet the demand for convenient and reliable transportation in these medical care deserts, thousands of hospitals partner directly with rideshare companies, some of which are authorized as non-emergency medical transportation services, to provide transportation to appointments and pharmacies. This story was produced by Lyft and reviewed and distributed by Stacker.
